FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3

Oncogene

Volumn 27, Issue 26, 2008, Pages 3641-3652

  Wilson, J B ^a   Yamamoto, K ^b,h   Marriott, A S ^a   Hussain, S ^c   Sung, P ^d   Hoatlin, M E ^e   Mathew, C G ^f   Takata, M ^b,i   Thompson, L H ^g   Kupfer, G M ^d   Jones, N J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f GUY S HOSPITAL   (United Kingdom)

^g LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^h Okayama Citizens Hospital   (Japan)

ⁱ KYOTO UNIVERSITY   (Japan)

Author keywords

ATR; DNA repair; Epistasis; Fanconi anemia; Interstrand crosslinks; RAD51 paralog; Replication restart

Indexed keywords

BRCA2 PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP F PROTEIN; FANCONI ANEMIA GROUP G PROTEIN; RAD51 PROTEIN; SERINE; XRCC3 PROTEIN; ATR PROTEIN, HUMAN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; FANCA PROTEIN, HUMAN; FANCD2 PROTEIN, HUMAN; FANCF PROTEIN, HUMAN; FANCG PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 3;

ANIMAL CELL; ARTICLE; CANCER SUSCEPTIBILITY; COMPLEX FORMATION; CONTROLLED STUDY; DNA CROSS LINKING; DNA REPAIR; FANCONI ANEMIA; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM; UBIQUITINATION; ANIMAL; CHICKEN; CHO CELL; CHROMOSOMAL INSTABILITY; CRICETULUS; GENETIC RECOMBINATION; HAMSTER; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

CRICETINAE;

ANIMALS; BRCA2 PROTEIN; CELL CYCLE PROTEINS; CHICKENS; CHO CELLS; CHROMOSOMAL INSTABILITY; CRICETINAE; CRICETULUS; DNA-BINDING PROTEINS; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP F PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP G PROTEIN; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECOMBINATION, GENETIC; SERINE;

EID: 45949110752     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1211034     Document Type: Article

References (80)

1. Alderton GK, Joenje H, Varon R, Borglum AD, Jeggo PA, O'Driscoll M. (2004). Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway. Hum Mol Genet 13: 3127-3138.
2. Alter BP. (1996). Fanconi's anemia and malignancies. Am J Hematol 53: 99-110.
3. Blom E, van de Vrugt HJ, de Vries Y, de Winter JP, Arwert F, Joenje H. (2004). Multiple TPR motifs characterize the Fanconi anemia FANCG protein. DNA Repair 3: 77-84.
4. Bogliolo M, Lyakhovich A, Callen E, Castella M, Cappelli E, Ramirez MJ et al. (2007). Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J 26: 1340-1351.
5. Bridge WL, Vandenberg CJ, Franklin RJ, Hiom K. (2005). The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat Genet 37: 953-957.
6. Busch DB, Zdzienicka MZ, Natarajan AT, Jones NJ, Overkamp WJI, Collins A et al. (1996). A CHO mutant, UV40, that is sensitive to diverse mutagens and represents a new complementation group of mitomycin C sensitivity. Mutat Res 363: 209-221.
7. Carreau M, Alon N, Bosnoyan-Collins L, Joenje H, Buchwald M. (1999). Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mutat Res 435: 103-109.
8. Ciccia A, Ling C, Coulthard R, Yan ZJ, Xue YT, Meetei AR et al. (2007). Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol Cell 25: 331-343.
9. Collins N, Kupfer GM. (2005). Molecular pathogenesis of Fanconi anemia. Int J Hematol 82: 176-183.
10. Davies AA, Masson JY, McLlwraith MJ, Stasiak AZ, Stasiak A, Venkitaraman AR et al. (2001). Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell 7: 273-282.
11. de Winter JP, van der Weel L, de Groot J, Stone S, Waisfisz Q, Arwert F et al. (2000). The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet 9: 2665-2674.
12. de Winter JP, Waisfisz Q, Rooimans MA, van Berkel CGM, Bosnoyan-Collins L, Alon N et al. (1998). The Fanconi anaemia group G gene FANCG is identical with XRCC9 . Nat Genet 20: 281-283.
13. Dronkert MLG, Kanaar R. (2001). Repair of DNA interstrand cross-links. Mutat Res 486: 217-247.
14. Esashi F, Christ N, Gannon J, Liu YL, Hunt T, Jasin M et al. (2005). CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434: 598-604.
15. Garcia-Higuera I, Kuang Y, Naf D, Wasik J, D'Andrea AD. (1999). Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol 19: 4866-4873.
16. Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J et al. (2001). Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 7: 249-262.
17. Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM et al. (1996). Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56: 5360-5364.
18. Gordon SM, Buchwald M. (2003). Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood 102: 136-141.
19. Gregory RC, Taniguchi T, D'Andrea AD. (2003). Regulation of the Fanconi anemia pathway by monoubiquitination. Semin Cancer Biol 13: 77-82.
20. Groves MR, Barford D. (1999). Topological characteristics of helical repeat proteins. Curr Opin Struct Biol 9: 383-389.
21. Gudmundsdottir K, Ashworth A. (2006). The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25: 5864-5874.
22. Henry-Mowatt J, Jackson D, Masson JY, Johnson PA, Clements PM, Benson FE et al. (2003). XRCC3 and Rad51 modulate replication fork progression on damaged vertebrate chromosomes. Mol Cell 11: 1109-1117.
23. Hinz JM, Nham PB, Salazar EP, Thompson LH. (2006). The Fanconi anemia pathway limits the severity of mutagenesis. DNA Repair 5: 875-884.
24. Hinz JM, Nham PB, Urbin SS, Jones IM, Thompson LH. (2007). Disparate contributions of the Fanconi anemia pathway and homologous recombination in preventing spontaneous mutagenesis. Nucleic Acids Res 35: 3733-3740.
25. Hirano S, Yamamoto K, Ishiai M, Yamazoe M, Seki M, Matsushita N et al. (2005). Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. EMBO J 24: 418-427.
26. Ho GPH, Margossian S, Taniguchi T, D'Andrea AD. (2006). Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance. Mol Cell Biol 26: 7005-7015.
27. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, de Die-Smulders C et al. (2002). Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297: 606-609.
28. Hussain S, Wilson JB, Blom E, Thompson LH, Sung P, Gordon SM et al. (2006). Tetratricopeptide-motif-mediated interaction of FANCG with recombination proteins XRCC3 and BRCA2. DNA Repair 5: 629-640.
29. Hussain S, Wilson JB, Medhurst AL, Hejna J, Witt E, Ananth S et al. (2004). Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum Mol Genet 13: 1241-1248.
30. Hussain S, Witt E, Huber PAJ, Medhurst AL, Ashworth A, Mathew CG. (2003). Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum Mol Genet 12: 2503-2510.
31. Johnson MA, Bryant PE, Jones NJ. (2000). Isolation of camptothecin-sensitive Chinese hamster cell mutants: phenotypic heterogeneity within the ataxia telangiectasia-like XRCC8 (irs2) complementation group. Mutagenesis 15: 367-374.
32. Johnson MA, Jones NJ. (1999). The isolation and genetic analysis of V79-derived etoposide sensitive Chinese hamster cell mutants: two new complementation groups of etoposide sensitive mutants. Mutat Res 435: 271-282.
33. Kennedy RD, D'Andrea AD. (2005). The Fanconi anemia/BRCA pathway: new faces in the crowd. Genes Dev 19: 2925-2940.
34. Kupfer GM, Naf D, Suliman A, Pulsipher M, D'Andrea AD. (1997). The Fanconi anaemia proteins, FAA and FAG, interact to form a nuclear complex. Nat Genet 17: 487-490.
35. Lamb JR, Tugendreich S, Hieter P. (1995). Tetratrico peptide repeat interactions - to Tpr or not to Tpr. Trends Biochem Sci 20: 257-259.
36. Lamerdin JE, Yamada NA, George JW, Souza B, Christian AT, Jones NJ et al. (2004). Characterization of the hamster FancG/Xrcc9 gene and mutations in CHOUV40 and NM3. Mutagenesis 19: 237-244.
37. Levitus M, Joenje H, de Winter JP. (2006). The Fanconi anemia pathway of genomic maintenance. Cell Oncol 28: 3-29.
38. Ling C, Ishiai M, Ali AM, Medhurst AL, Neveling K, Kalb R et al. (2007). FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J 26: 2104-2114.
39. Liu N, Lamerdin JE, Tebbs RS, Schild D, Tucker JD, Shen MR et al. (1998). XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol Cell 1: 783-793.
40. Liu N, Schild D, Thelen MP, Thompson LH. (2002). Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells. Nucleic Acids Res 30: 1009-1015.
41. Lyakhovich A, Surralles J. (2007). New roads to FA/BRCA pathway-H2AX. Cell Cycle 6: 1019-1023.
42. Masson JY, Tarsounas MC, Stasiak AZ, Stasiak A, Shah R, McIlwraith MJ et al. (2001). Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev 15: 3296-3307.
43. Mathew CG. (2006). Fanconi anaemia genes and susceptibility to cancer. Oncogene 25: 5875-5884.
44. Meetei AR, Medhurst AL, Ling C, Xue YT, Singh TR, Bier P et al. (2005). A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet 37: 958-963.
45. Mi J, Qiao F, Wilson JB, High AA, Schroeder MJ, Stukenberg PT et al. (2004). FANCG is phosphorylated at serines 383 and 387 during mitosis. Mol Cell Biol 24: 8576-8585.
46. Mirchandani KD, D'Andrea AD. (2006). The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair. Exp Cell Res 312: 2647-2653.
47. Nakanishi K, Yang YG, Pierce AJ, Taniguchi T, Digweed M, D'Andrea AD et al. (2005). Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc Natl Acad Sci USA 102: 1110-1115.
48. Niedernhofer LJ. (2007). The Fanconi anemia signalosome anchor. Mol Cell 25: 487-490.
49. Niedzwiedz W, Mosedale G, Johnson M, Ong CY, Pace P, Patel KJ. (2004). The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. Mol Cell 15: 607-620.
50. O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA. (2003). A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet 33: 497-501.
51. Ohashi A, Zdzienicka MZ, Chen JJ, Couch FJ. (2005). Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage. J Biol Chem 280: 14877-14883.
52. Pace P, Johnson M, Tan WM, Mosedale G, Sng C, Hoatlin M et al. (2002). FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J 21: 3414-3423.
53. Patel KJ, Joenje H. (2007). Fanconi anemia and DNA replication repair. DNA Repair 6: 885-890.
54. Qiao FY, Mi J, Wilson JB, Zhi G, Bucheimer NR, Jones NJ et al. (2004). Phosphorylation of Fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway. J Biol Chem 279: 46035-46045.
55. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R et al. (2007). Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 39: 162-164.
56. Sarkaria JN, Tibbetts RS, Busby EC, Kennedy AP, Hill DE, Abraham RT. (1998). Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res 58: 4375-4382.
57. Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald ER, Hurov KE, Luo J et al. (2007). Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129: 289-301.
58. Takata M, Sasaki MS, Sonoda E, Morrison C, Hashimoto M, Utsumi H et al. (1998). Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J 17: 5497-5508.
59. Takata M, Sasaki MS, Tachiiri S, Fukushima T, Sonoda E, Schild D et al. (2001). Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs. Mol Cell Biol 21: 2858-2866.
60. Taniguchi T, D'Andrea AD. (2006). Molecular pathogenesis of Fanconi anemia: recent progress. Blood 107: 4223-4233.
61. Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST et al. (2002). Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109: 459-472.
62. Tebbs RS, Hinz JM, Yamada NA, Wilson JB, Salazar EP, Thomas CB et al. (2005). New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant. DNA Repair 4: 11-22.
63. Thacker J. (2005). The RAD51 gene family, genetic instability and cancer. Cancer Lett 219: 125-135.
64. Thompson LH. (2005). Unraveling the Fanconi anemia-DNA repair connection. Nat Genet 37: 921-922.
65. Thompson LH, Hinz JM, Yamada NA, Jones NJ. (2005). How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery. Environ Mol Mutagen 45: 128-142.
66. Waisfisz Q, de Winter JP, Kruyt FAE, de Groot J, van der Weel L, Dijkmans LM et al. (1999). A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc Natl Acad Sci USA 96: 10320-10325.
67. Wang WD. (2007). Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 8: 735-748.
68. Wang XZ, Andreassen PR, D'Andrea AD. (2004). Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol 24: 5850-5862.
69. Whitney M, Thayer M, Reifsteck C, Olson S, Smith L, Jakobs PM et al. (1995). Microcell mediated chromosome transfer maps the Fanconi-anemia-group-D gene to chromosome-3p. Nat Genet 11: 341-343.
70. Wiegant WW, Overmeer RM, Godthelp BC, van Buul PPW, Zdzienicka MZ. (2006). Chinese hamster cell mutant, V-C8, a model for analysis of BRCA2 function. Mutat Res 600: 79-88.
71. Wilson JB, Johnson MA, Stuckert AP, Trueman KL, May S, Bryant PE et al. (2001). The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange. Carcinogenesis 22: 1939-1946.
72. Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q et al. (2007). Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39: 159-161.
73. Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu JM, Christ N et al. (2006). Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol Cell 22: 719-729.
74. Yamada NA, Hinz JM, Kopf VL, Segalle KD, Thompson LH. (2004). XRCC3 ATPase activity is required for normal XRCC3-Rad51C complex dynamics and homologous recombination. J Biol Chem 279: 23250-23254.
75. Yamamoto K, Ishiai M, Matsushita N, Arakawa H, Lamerdin JE, Buerstedde JM et al. (2003). Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells. Mol Cell Biol 23: 5421-5430.
76. Yamashita T, Kupfer GM, Naf D, Suliman A, Joenje H, Asano S et al. (1998). The Fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc Natl Acad Sci USA 95: 13085-13090.
77. Yamashita YM, Okada T, Matsusaka T, Sonoda E, Zhao GY, Araki K et al. (2002). RAD18 and RAD54 cooperatively maintenance of genomic stability cells. EMBO J 21: 5558-5566.
78. Yang YG, Herceg Z, Nakanishi K, Demuth I, Piccoli C, Michelon J et al. (2005). The Fanconi anemia group A protein modulates homologous repair of DNA double-strand breaks in mammalian cells. Carcinogenesis 26: 1731-1740.
79. Zhang N, Liu X, Li L, Legerski R. (2007). Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway. DNA Repair 6: 1670-1678.
80. Zhang Y, Wienands J, Zurn C, Reth M. (1998). Induction of the antigen receptor expression on B lymphocytes results in rapid competence for signaling of SLP-65 and Syk. EMBO J 17: 7304-7310.